Timothy Haines

Timothy Haines is a declared insider at 2 companies; the most frequent names are Sientra, Inc. and Protara Therapeutics, Inc. Over a trading history stretching from 27 October 2014 to 12 November 2019, the count stands at 11 filings.

Both buying and selling appear: 3 purchases worth €16.5M, against 2 sales worth €1.7M. On balance, insiders were net buyers of €14.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants.

The median purchase comes to €5.8M.

Most recently, on 14 November 2019, the filings show a transaction worth €114k in Protara Therapeutics, Inc. The latest purchase dates back some time: it was published 3,106 days ago, on 9 May 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.